Completion of PIONEER III randomized, controlled trial by SINOMED

In a significant breakthrough towards obtaining the major regulatory approvals for the BuMA Supreme Drug-Eluting Stent System, enrollment in the PIONEER III randomized, controlled trial has been completed by SINOMED. For assessing the safety & effectiveness of the BuMa Supreme…

Examination of Pulmonary Arterial Hypertension (PAH)

Recently added to the massive repository of QYReports, The Therapeutics Market Report i.e. Pulmonary Arterial Hypertension (PAH) is a comprehensive study of the global market. Techniques have been used regarding data exploration for the compilation of the targeted market data.…